Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Actavis Waits On Alimta Hybrid Following FDA Approval
Teva’s Actavis Obtains NDA Approval
Sep 02 2020
•
By
Dean Rudge
The FDA has approved Actavis' pemetrexed NDA but launch if off the cards for now • Source: Shutterstock
More from Products
More from Generics Bulletin